Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer.

Victoria García-Ortiz, María; Cano-Ramírez, Pablo; Toledano-Fonseca, Marta; Teresa Cano, María; Inga-Saavedra, Elizabeth; María Rodríguez-Alonso, Rosa; Guil-Luna, Silvia; Auxiliadora Gómez-España, María; Rodríguez-Ariza, Antonio; Aranda, Enrique

doi:10.1186/s13148-023-01535-4

Public

Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer.

Shared by NobleBlocks on Jul 22, 2023 • 12:00 AM UTC

Authors:

María Victoria García-Ortiz

Pablo Cano-Ramírez

Marta Toledano-Fonseca

Abstract

BACKGROUND: Pancreatic cancer is the most lethal cancer with a dismal prognosis mainly due to diagnosis at advanced stage and ineffective treatments. CA19-9 levels and computed tomography (CT) imaging are the main standard criteria for evaluating disease progression and treatment response. In this s...

Subject

CA19-9

DNA methylation

Epigenetic biomarker

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!